Vimarsana
Biggest News Aggregation in the World

Page 8 - Integrated Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrated Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrated Research Today - Breaking & Trending Today

Wayne State will play up assets against UM, MSU, new leader Espy says - Vimarsana News

Wayne State will play up assets against UM, MSU, new leader Espy says

Incoming Wayne State University President Kimberly Andrews Espy said the university welcomes competition from Michigan's two largest universities.

Ashwini Vaishnaw: 'If you have to go green, then we as a country must invest significantly in railways' - Vimarsana News

Ashwini Vaishnaw: 'If you have to go green, then we as a country must invest significantly in railways'

At an Adda held in New Delhi on May 20, Ashwini Vaishnaw, Union Minister for Railways, Communications, Electronics and Information Technology, spoke on increased investment in railways, rollout of the Vande Bharat trains and how India can become the biggest chip producer.

AIIA kick starts its International Yoga Day 2023 celebrations - Vimarsana News

AIIA kick starts its International Yoga Day 2023 celebrations

All India Institute of Ayurveda (AIIA) under the Ministry of Ayush kickstarted its celebrations in the run-up to the 9th International Day of Yoga. Dr Hansa Yogendra, Director Yoga Institute, Mumbai was the Chief Guest for the curtain raiser programm

Yoga Day 2023: All India Institute of Ayurveda kick starts celebrations under Ministry of Ayush - Vimarsana News

Yoga Day 2023: All India Institute of Ayurveda kick starts celebrations under Ministry of Ayush

All India Institute of Ayurveda (AIIA), an autonomous organisation under the Ministry of Ayush (MoA), Government of India, kickstarted its Yoga Day celebrations

Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer - Vimarsana News

Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer

XTANDI (enzalutamide) is an androgen receptor signaling inhibitor.